Résumé
L’assistance circulatoire type extracorporeal membrane oxygenation (ECMO) peut être utilisée en cas de défaillances respiratoires et/ou circulatoires réfractaires aux traitements conventionnels. Son utilisation est en constante augmentation, et associée à la survenue de complications du système nerveux, responsables d’une morbimortalité élevée. Les complications neurologiques observées sous ECMO sont principalement cérébrovasculaires, accident vasculaire cérébral ischémique (AVCi) et hémorragie intracrânienne (HIC). De nombreux éléments antérieurs à l’implantation de l’ECMO peuvent être associés à la survenue de lésions neurologiques, mais certaines complications neurologiques sont plus fréquemment observées selon le type d’ECMO utilisée. Les AVCi surviennent principalement chez les patients sous ECMO-veinoartérielle, alors que les HIC sont surtout observés chez les patients sous EMCO-veinoveineuse. La survenue de ces complications neurologiques a un impact sur les choix thérapeutiques, reposant sur l’estimation multidisciplinaire du rapport bénéfice/risque. Leur détection précoce pourrait améliorer le pronostic des patients.
Abstract
Extracorporeal membrane oxygenation (ECMO) is used to support patients with respiratory and/or circulatory failure refractory to conventional therapies. Its use is increasing and associated with nervous system complications, responsible for high morbidity and mortality. These neurological events are mainly cerebrovascular in nature; that is, ischemic stroke and cerebral hemorrhage. Many pre-ECMO factors are associated with neurological injury but during the course of ECMO, the modality used is also diversely associated with nervous system complication. Stroke occurs mainly during venoarterial ECMO, whereas cerebral hemorrhage is mostly observed during venovenous ECMO. These complications have an important impact in terms of outcome, and consequently on multidisciplinary teams decisions. Early detection and specific care for neurological complications could improve the prognosis of these patients.
Références
Luyt CE, Combes A, Becquemin MH, et al (2012) Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest 142:583–92
Combes A, Brodie D, Bartlett R, et al (2014) Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 190:488–96
Davies A, Jones D, Bailey M, et al (2009) Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302:1888–95
Marasco SF, Lukas G, McDonald M, et al (2008) Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 17:S41–S7
Lago P, Rebsamen S, Clancy RR, et al (1995) MRI, MRA, and neurodevelopmental outcome following neonatal ECMO. Pediatr Neurol 12:294–304
Black MD, Coles JG, Williams WG, et al (1995) Determinants of success in pediatric cardiac patients undergoing extracorporeal membrane oxygenation. Ann Thorac Surg 60:133–8
Barrett CS, Bratton SL, Salvin JW, et al (2009) Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation. Pediatr Crit Care Med 10:445–51
Lewandowski K, Rossaint R, Pappert D, et al (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23:819–35
Mateen FJ, Muralidharan R, Shinohara RT, et al (2011) Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol 68:1543–9
Lee JJ, Han SJ, Kim HS, et al (2016) Out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal membrane oxygenation: focus on survival rate and neurologic outcome. Scand J Trauma Resusc Emerg Med 24:74
Posluszny J, Rycus PT, Bartlett RH, et al (2016) Outcome of adult respiratory failure patients receiving prolonged (≥ 14 days) ECMO. Ann Surg 263:573–81
Nasr DM, Rabinstein AA (2015) Neurologic complications of extracorporeal membrane oxygenation. J Clin Neurol 11:383–9
Mehta A, Ibsen LM (2013) Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med 2:40–7
Luyt CE, Bréchot N, Demondion P, et al (2016) Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 42:897–907
Ryu JA, Cho YH, Sung K, et al (2015) Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation. BMC Anesthesiol 15:26
Risnes I, Wagner K, Nome T, et al (2006) Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation. Ann Thorac Surg 81:1401–6
Omar HR, Mirsaeidi M, Shumac J, et al (2016) Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support. J Crit Care 32:48–51
Meyer AD, Gelfond JA, Wiles AA, et al (2015) Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems. Asaio J 61:37–42
Nomura S, Shimizu M (2015) Clinical significance of procoagulant microparticles. J Intensive Care 3:2
Foster PP, Boriek AM, Butler BD, et al (2003) Patent foramen ovale and paradoxical systemic embolism: a bibliographic review. Aviat Space Environ Med 74:B1–B64
Stocchetti N, Maas AI, Chieregato A, et al (2005) Hyperventilation in head injury: a review. Chest. 127:1812–27
Hornig CR, Dorndorf W, Agnoli AL (1986) Hemorrhagic cerebral infarction — a prospective study. Stroke 17:179–85
Kasirajan V, Smedira NG, McCarthy JF, et al (1999) Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 15:508–14
Muehrcke DD, McCarthy PM, Stewart RW, et al (1995) Complications of extracorporeal life support systems using heparinbound surfaces. The risk of intracardiac clot formation. J Thorac Cardiovasc Surg 110:843–51
Biehl DA, Stewart DL, Forti NH, et al (1996) Timing of intracranial hemorrhage during extracorporeal life support. ASAIO J 42:938–41
Omar HR, Mirsaeidi M, Mangar D, et al (2016) Duration of ECMO is an independent predictor of intracranial hemorrhage occurring during ECMO support. Asaio J 14:14
Martucci G, Lo Re V, Arcadipane A (2016) Neurological injuries and extracorporeal membrane oxygenation: the challenge of the new ECMO era. Neurol Sci 19:19
Davenport A (1997) The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 30:S20–S7
Mezzano D, Tagle R, Panes O, et al (1996) Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 76:312–21
Webb AR, Mythen MG, Jacobson D, Mackie IJ (1995) Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation. Intensive Care Med 21:84–93
Hingorani A, Ascher E, Tsemekhim B, et al (2002) Causes of early post carotid endartectomy stroke in a recent series: the increasing importance of hyperperfusion syndrome. Acta Chir Belg 102:435–8
Schrag M, Greer DM (2014) Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis 23:2489–97
Le Guennec L, Bertrand A, Laurent C, et al (2015) Diffuse cerebral microbleeds after extracorporeal membrane oxygenation support. Am J Respir Crit Care Med 191:594–6
Samadi B, Nguyen D, Rudham S, Barnett Y (2016) Spinal cord infarct during concomitant circulatory support with intra-aortic balloon pump and veno-arterial extracorporeal membrane oxygenation. Crit Care Med 44:e101–e5
Stavridis GT, O’Riordan JB (1995) Paraplegia as a result of intra-aortic balloon counterpulsation. J Cardiovasc Surg (Torino) 36:177–9
Beholz S, Braun J, Ansorge K, et al (1998) Paraplegia caused by aortic dissection after intraaortic balloon pump assist. Ann Thorac Surg 65:603–4
Bladin CF, Alexandrov AV, Bellavance A, et al (2000) Seizures after stroke: a prospective multicenter study. Arch Neurol 57:1617–22
Brignole M, Alboni P, Benditt D, et al (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256–306
Giani M, Scaravilli V, Colombo SM, et al (2016) Apnea test during brain death assessment in mechanically ventilated and ECMO patients. Intensive Care Med 42:72–81
Nguyen DN, Huyghens L, Wellens F, et al (2014) Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO). Neurocrit Care 20:367–74
Go JY, Min YS, Jung TD (2014) Delayed onset of acute limb compartment syndrome with neuropathy after venoarterial extracorporeal membrane oxygenation therapy. Ann Rehabil Med 38:575–80
Mittal MK, Schears GJ, Wijdicks EF (2013) Brachial plexus injury associated with extracorporeal membrane oxygenation. J Clin Neuromuscul Dis 15:24–7
Bitsch A, Horn C, Kemmling Y, et al (2002) Serum tau protein level as a marker of axonal damage in acute ischemic stroke. Eur Neurol 47:45–51
Missler U, Wiesmann M, Friedrich C, Kaps M (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956–60
Herrmann M, Vos P, Wunderlich MT, et al (2000) Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31:2670–7
Montaner J, Mendioroz M, Delgado P, et al (2012) Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. J Proteomics 75:4758–65
Pugin D, Woimant F (2012) Stroke care in the ICU: general supportive treatment. Experts’ recommendations. Rev Neurol (Paris) 168:490–500
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457–507
Weis F, Beiras-Fernandez A, Bruegger D, et al (2009) Huge intracardiac thrombosis in a patient on veno-arterial extracorporeal membrane oxygenation support. Interact Cardiovasc Thorac Surg 8:247–9
Muehrcke DD, McCarthy PM, Stewart RW, et al (1995) Complications of extracorporeal life support systems using heparinbound surfaces. The risk of intracardiac clot formation. J Thorac Cardiovasc Surg 110:843–51
Gouin-Thibaut I, Martin-Toutain I, Peynaud-Debayle E, et al (2012) Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents. Thromb Res 129:666–7
Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387:2605–13
Nei SD, Wittwer ED, Kashani KB, et al (2015) Levetiracetam pharmacokinetics in a patient receiving continuous venovenous hemofiltration and venoarterial extracorporeal membrane oxygenation. Pharmacotherapy 35:e127–e30
Piper C, Wiemer M, Schulte HD, et al (2001) Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 10:703–11
Gillinov AM, Shah RV, Curtis WE, et al (1996) Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 61:1125–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Guennec, L., Schmidt, M., Bréchot, N. et al. Complications neurologiques de l’assistance circulatoire de courte durée. Réanimation 25 (Suppl 4), 150–160 (2016). https://doi.org/10.1007/s13546-016-1217-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-016-1217-4